☆ 4.5 Article

Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities

ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)

Get Full Text
Add to Collection

Journal

ANNALS OF THE AMERICAN THORACIC SOCIETY
Volume 16, Issue 5, Pages 534-539

Publisher

AMER THORACIC SOC
DOI: 10.1513/AnnalsATS.201812-863OT

Keywords

-

Categories

Respiratory System

Funding

  1. Cystic Fibrosis Foundation [RAMSEY03Y0]
  2. National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) [5RO1HL124053]
  3. NIH/NIDDK [5P30DK089507]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.